Articles dans des revues avec comité de lecture (154)

  1. 47. Vachiery, J.-L. (2016). Cas clinique n° 2. Revue des Maladies Respiratoires Actualites, 8(1), 13-14. doi:10.1016/S1877-1203(16)30044-1
  2. 48. Vanden Eynden, F., Racapé, J., Vincent, J., Vachiery, J.-L., Bové, T., & Van Nooten, G. (2016). The linear relationship between systolic pulmonary artery pressure and mean pulmonary artery pressure is maintained regardless of autonomic or rhythm disturbances. Respiratory research, 17(1), 33. doi:10.1186/s12931-016-0350-7
  3. 49. Esmaeil Zadeh, F., Dendievel, R., Wauters, A., Vachiery, J.-L., Van Nooten, G., Van De Borne, P., & Argacha, J.-F. (2016). Does third generation left ventricular assist device alter heart failure-related microvascular dysfunction? Acta cardiologica, 71(4), 403-410. doi:10.2143/AC.71.4.3159692
  4. 50. Vanden Eynden, F., Bol Alima, M., Racapé, J., El Oumeiri, B. G., Vachiery, J.-L., & Van Nooten, G. (2016). Composite indices of upstream pulmonary vascular impedance and capacitance do not help in identifying patients who should undergo pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Acta cardiologica, 71(3), 281-290. doi:10.2143/AC.71.3.3152088
  5. 51. Vicenzi, M., Deboeck, G., Faoro, V., Loison, J., Vachiery, J.-L., & Naeije, R. (2016). Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension. International journal of cardiology, 202, 736-740. doi:10.1016/j.ijcard.2015.09.087
  6. 52. Wauters, A., Vicenzi, M., De Becker, B., Riga, J.-P., Esmaeil Zadeh, F., Faoro, V., Vachiery, J.-L., Van De Borne, P., & Argacha, J.-F. (2015). At high cardiac output, diesel exhaust exposure increases pulmonary vascular resistance and decreases distensibility of pulmonary resistive vessels. American journal of physiology. Heart and circulatory physiology, 309(12), H2137-H2144. doi:10.1152/ajpheart.00149.2015
  7. 53. Vanden Eynden, F., Antoine, M., El Oumeiri, B. G., Chirade, M.-L., Vachiery, J.-L., & Van Nooten, G. J. (2015). How to cope with a temporarily aborted transplant program: solutions for a prolonged waiting period. Annals of translational medicine, 3(20), 306. doi:10.3978/j.issn.2305-5839.2015.11.30
  8. 54. Galie, N., Grünig, E., Oudiz, R. J., Vonk-Noordegraaf, A., White, R. J., Blair, C., Gillies, H., Miller, K. K., Harris, J. H. N., Langley, J., Rubin, L., Barberà, J. A., Frost, A., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V., Peacock, A. J. A., Simonneau, G., & Vachiery, J.-L. (2015). Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. The New England journal of medicine, 373(9), 834-844. doi:10.1056/NEJMoa1413687
  9. 55. Webb, D. J., Vachiery, J.-L., Hwang, L. J., & Maurey, J. O. (2015). Sildenafil improves renal function in patients with pulmonary arterial hypertension. British journal of clinical pharmacology, 80(2), 235-241. doi:10.1111/bcp.12616
  10. 56. Vachiery, J.-L., & Rubin, L. (2015). Navigating the uncharted waters of combination therapy in pulmonary arterial hypertension: COMPASS or dead-reckoning. The European respiratory journal, 46(2), 297-298. doi:10.1183/13993003.00907-2015
  11. 57. Cheli, M., & Vachiery, J.-L. (2015). Controversies in pulmonary hypertension due to left heart disease. F1000Prime Reports, 7, 07. doi:10.12703/P7-07
  12. 58. Maruyama, H., Dewachter, C., Belhaj, A., Rondelet, B., Sakai, S., Remmelink, M., Vachiery, J.-L., Naeije, R., & Dewachter, L. (2014). Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension. The Journal of heart and lung transplantation. doi:10.1016/j.healun.2014.09.011

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Suivant >>